Engineered nanozymes enhance atherosclerosis therapy via inflammation-lipid homeostasis modulation

Puntos clave

• Enhanced lipid homeostasis was achieved, leading to reduced inflammation in atherosclerosis models.
• The study observed that engineered nanozymes significantly reduced inflammation markers by 40%.
• Assessment of treatment efficacy using lipid profiles and inflammatory cytokines demonstrated the benefits of nanozymes.
• Support for this approach may lead to novel therapeutic applications for managing atherosclerosis.